ATE471982T1 - Biologische variabilität von asthma-assoziiertem faktor 2 aaf2 (il-9 rezeptor) nützlich für die behandlung und diagnose von atopischen allergien wie asthma und asthma-ähnlichen erkrankungen - Google Patents

Biologische variabilität von asthma-assoziiertem faktor 2 aaf2 (il-9 rezeptor) nützlich für die behandlung und diagnose von atopischen allergien wie asthma und asthma-ähnlichen erkrankungen

Info

Publication number
ATE471982T1
ATE471982T1 AT04013403T AT04013403T ATE471982T1 AT E471982 T1 ATE471982 T1 AT E471982T1 AT 04013403 T AT04013403 T AT 04013403T AT 04013403 T AT04013403 T AT 04013403T AT E471982 T1 ATE471982 T1 AT E471982T1
Authority
AT
Austria
Prior art keywords
asthma
aaf2
diagnosis
treatment
atopic
Prior art date
Application number
AT04013403T
Other languages
German (de)
English (en)
Inventor
Roy Levitt
Luigi Grasso
Nicholas Nicolaides
Original Assignee
Genaera Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genaera Corp filed Critical Genaera Corp
Application granted granted Critical
Publication of ATE471982T1 publication Critical patent/ATE471982T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT04013403T 1996-12-02 1997-12-02 Biologische variabilität von asthma-assoziiertem faktor 2 aaf2 (il-9 rezeptor) nützlich für die behandlung und diagnose von atopischen allergien wie asthma und asthma-ähnlichen erkrankungen ATE471982T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3222496P 1996-12-02 1996-12-02
US98087297A 1997-12-01 1997-12-01

Publications (1)

Publication Number Publication Date
ATE471982T1 true ATE471982T1 (de) 2010-07-15

Family

ID=26708147

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04013403T ATE471982T1 (de) 1996-12-02 1997-12-02 Biologische variabilität von asthma-assoziiertem faktor 2 aaf2 (il-9 rezeptor) nützlich für die behandlung und diagnose von atopischen allergien wie asthma und asthma-ähnlichen erkrankungen

Country Status (8)

Country Link
EP (1) EP0942979A2 (es)
JP (2) JP4552076B2 (es)
AT (1) ATE471982T1 (es)
AU (1) AU746595B2 (es)
CA (1) CA2271952C (es)
DE (1) DE69739920D1 (es)
ES (1) ES2347962T3 (es)
PT (1) PT1471144E (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119040500B (zh) * 2024-07-18 2026-04-17 中国农业科学院作物科学研究所 与大豆种子油份、蛋白含量和百粒重相关的snp分子标记与应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2666298A1 (en) * 1995-08-24 1997-03-06 Genaera Corporation Asthma associated factors as targets for treating atopic allergies including asthma and related disorders

Also Published As

Publication number Publication date
PT1471144E (pt) 2010-08-17
ES2347962T3 (es) 2010-11-26
CA2271952C (en) 2010-04-06
JP2009159976A (ja) 2009-07-23
DE69739920D1 (de) 2010-08-05
AU5689198A (en) 1998-06-29
AU746595B2 (en) 2002-05-02
EP0942979A2 (en) 1999-09-22
CA2271952A1 (en) 1998-06-11
JP2002514911A (ja) 2002-05-21
JP4552076B2 (ja) 2010-09-29

Similar Documents

Publication Publication Date Title
Sun et al. Distinct profiles of REST interactions with its target genes at different stages of neuronal development
Fan et al. Polyglutamine (PolyQ) diseases: genetics to treatments
Sinha et al. Cellular mechanisms of β-amyloid production and secretion
Wechselberger et al. The mammalian homologues of frog Bv8 are mainly expressed in spermatocytes
DE69117949D1 (de) Mit akuter pankreatitis assoziiertes protein, mittel zur diagnose von akuter pankreatitis
Hadas et al. Temporal BMP4 effects on mouse embryonic and extraembryonic development
EP0750672A1 (de) Dna-sequenzen für matrix-metallproteasen, ihre herstellung und verwendung
RU2003105882A (ru) Упорядоченный железосодержащий белок-2 в качестве диагностического средства при нейродегенеративных заболеваниях
WO1998024904A3 (en) Il-9 receptor variants, useful in treating and diagnosing atopic allergies including asthma and related disorders
DE19805633A1 (de) Neue Serinprotease aus der Prostata
Qian et al. Identification of a new mutant allele, Grm6nob7, for complete congenital stationary night blindness
Nef How we smell: the molecular and cellular bases of olfaction
ATE471982T1 (de) Biologische variabilität von asthma-assoziiertem faktor 2 aaf2 (il-9 rezeptor) nützlich für die behandlung und diagnose von atopischen allergien wie asthma und asthma-ähnlichen erkrankungen
ATE375389T1 (de) Verfahren zur diagnose, prognose und behandlung von glaukom und verwandten erkrankungen
Razani et al. Molecular cloning and developmental expression of the caveolin gene family in the amphibian Xenopus laevis
DE60037126D1 (de) POLYMORPHISMEN DES MENSCHLICHEN HPXR Gens UND IHRE ANWENDUNG IN DIAGNOSE UND THERAPIE
CN107058254A (zh) 阿尔茨海默病新致病基因及其医药用途
ATE517629T1 (de) Verwendung eines proteins der crmp familie zur behandlung von krankheiten des immunsystems
DE602004026683D1 (de) Verfahren zur diagnose und überwachung von neurologischen erkrankungen durch nachweis eines encephalotoxins
DE502005004379D1 (de) Gegen den Marburg I Polymorphismus der Faktor VII aktivierenden Protease (FSAP) gerichtete Antikörper, ihre Herstellung und Verwendung
Dai et al. CCNK Gene Deficiency Influences Neural Progenitor Cells via Wnt5a Signaling in CCNK‐Related Syndrome
Duński et al. Keeping the balance: Trade-offs between human brain evolution, autism, and schizophrenia
HUP0100674A2 (hu) Mutáns prepo-neuropeptid-Y-t kódoló DNS-molekula, mutáns szignálpeptid és alkalmazásuk
Lacovich et al. Developmental deletion of amyloid precursor protein precludes transcriptional and proteomic responses to brain injury
WO2005071107A1 (de) A141s- und g399s-mutation im omi/htra2-protein bei morbus parkinson

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties